Demulcent Eye Drops Market Size by Active Pharmaceutical Ingredient Type (Cellulose Derivatives, Dextran 70, Polyols, Polymers), By Drug formulation (Preservative Based, Non-Preservative Based), Medication Type, Distribution Channel & Forecast, 2022 - 2030

Demulcent Eye Drops Market Size by Active Pharmaceutical Ingredient Type (Cellulose Derivatives, Dextran 70, Polyols, Polymers), By Drug formulation (Preservative Based, Non-Preservative Based), Medication Type, Distribution Channel & Forecast, 2022 - 2030

Demulcent Eye Drops Market Size

Demulcent Eye Drops Market size was worth more than USD 1.8 billion in 2021 and is expected to grow at a CAGR of more than 6% through 2030. Easy product accessibility and increased availability will push industry growth.
 

Growing cases of various eye disorders across the world is the primary factor propelling the market expansion. Recent data reveals that dry eye disease (DED) affects around 5% adult Americans. Notably, DED leads to numerous complications such as microaneurysm, optic nerve injury, and retinal thickness. Increase in instances of dry eye disease is one of the main factors that will boost demand for demulcent eye drops.  Additionally, higher pervasiveness of ocular ailments across developing nations, especially among geriatric population will augment the demulcent eye drops market outlook.
 

Demulcent Eye Drops Market Trends

One of the key factors preventing the business from growing is the fact that demulcent eye drops, which are readily available over-the-counter, have a variety of negative effects. These eye drops are preserved using ingredients including purite, EDTA, and BAK to maintain pH level of tear film. Excessive or incorrect usage of such medications may cause adverse reactions such as allergies and ocular toxicity. The looming chances of discontinuation of certain ocular eye drops with preservatives may restrain the market growth.
 

Demulcent Eye Drops Market Analysis

The demulcent eye drops market is divided into polyols, dextran 70, polymers, cellulose derivatives, and others, based on active pharmaceutical ingredient types. The polyols segment crossed USD 550 million in 2021. The cases of digital eye strain is rising as a result of the growing usage of electronic gadgets. Furthermore, a notable rise in retinal diseases and eye treatments has stimulated segment share.
 

Depending on drug formulation, the demulcent eye drops market is segmented into preservative based and non-preservative-based products. The non-preservative-based segment is set to surpass USD 1 billion by 2030. Preservatives such as sodium chlorite, benzalkonium chloride (BAK), etc. are used in eye drop formulations which are harmful at times.
 

The non-preservative-based demulcent eye drops segment is expected to develop in the forthcoming years owing to consumer preference for product due to the growing awareness of the eye-health risks caused by preservatives.
 

The market is categorized into over the counter (OTC) and prescriptions, as per medication type. The OTC segment exceeded USD 1 billion in 2021. Over-the-counter medications are the ones that may be purchased without a prescription, ensuring easier access to pharmaceuticals. Increased availability and accessibility of demulcent eye drops to the general public through OTC is impelling the segment demand.
 

In terms of distribution channel, worldwide demulcent eye drops market is categorized into retail pharmacies, online pharmacies, and hospital pharmacies. The retail pharmacies segment held more than 50% business share in 2021 and is projected to record significant growth rate over the study period. The availability of affordable demulcent eye drops at retail medical stores and the rising acceptance of over-the-counter products are giving push to the industry value.
 

Europe demulcent eye drops market is anticipated to surpass USD 875 million by 2030. This is due to growing elderly population base and the significant increase in the patients suffering from dry eye disease in the European nations. The product demand will soar in the coming years, resulting from the consequences of DED such as corneal ulcers, vision loss, and decreased quality of life.
 

Demulcent Eye Drops Market Share

Firms like

• Johnson and Johnson Services Inc.
• Alcon Inc.
• OASIS Medical
• Allegan (AbbVie Inc.)
• Prestige Consumer Healthcare Inc.
• Santen Pharmaceutical Co. Ltd.
• Bausch Health Companies Inc.
• Aurolab
• Otsuka Pharmaceutical Co.,Ltd.
• Sentiss Pharma Pvt. Ltd.
• Sun Pharmaceutical Industries Ltd.
• URSAPHARM Arzneimittel GmbH

are the major competitors in the demulcent eye drops market.
 

In order to establish a strong market position, the manufacturers are strategically focusing on creating innovative solutions to meet the requirements of the customers. For instance, in January 2022, Systane Complete Preservative-Free Lubricant Eye Drops was made available in Europe by Alcon. This strategy widened Alcon's footprint in the massive and rapidly expanding artificial tears industry, generating sales worth over USD 1 billion annually.
 

Impact of COVID-19 Pandemic

The COVID-19 outbreak negatively affected almost every industry and organization, irrespective of size, plummeting the global economy. Due to the lack of both critical and non-essential medical supplies, there was a turmoil in the medical sector. The disruption of the supply chain impacted the production and shipping of demulcent eye drops, hampering the industry growth. However, growing sales of OTC demulcent eye drops, in tandem with shifting consumer preference for purchasing through online pharmacies will aid the global market to recover and grow in the coming years.
 

The demulcent eye drops market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2017 to 2030, for the following segments

Click here to Buy Section of this Report

By Active Pharmaceutical Ingredient Type

• Cellulose Derivatives
• Dextran 70
• Polyols
• Polymers
• Others

By Drug Formulation

• Preservative Based
• Non-Preservative Based

By Medication Type

• Over-the-counter (OTC)
• Prescription

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

The above information is provided for the following regions and countries

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Others
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Others